Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,628 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low TLR and PSMA-TV predict biochemical response to abiraterone acetate in metastatic prostate cancer patients developing castration resistance after chemohormonal therapy at hormone-sensitive stage.
Ke ZB, Chen JY, You Q, Sun JB, Xue YT, Ye XJ, Chen SH, Xue XY, Sun XL, Chen DN, Wei Y, Zheng QS, Chen SM, Xu N. Ke ZB, et al. Among authors: you q. J Cancer Res Clin Oncol. 2023 Jul;149(8):5071-5084. doi: 10.1007/s00432-022-04438-8. Epub 2022 Nov 4. J Cancer Res Clin Oncol. 2023. PMID: 36333565
Head-to-head comparisons of [68Ga]Ga-PSMA-11 PET/CT, multiparametric MRI, and prostate-specific antigen for the evaluation of therapeutic responses to neoadjuvant chemohormonal therapy in high-risk non-metastatic prostate cancer patients: a prospective study.
Ke ZB, Chen SM, Chen JY, Chen SH, You Q, Sun JB, Xue YT, Sun XL, Wu XH, Zheng QS, Wei Y, Xue XY, Xu N. Ke ZB, et al. Among authors: you q. Eur J Nucl Med Mol Imaging. 2023 Mar;50(4):1240-1251. doi: 10.1007/s00259-022-06047-6. Epub 2022 Nov 22. Eur J Nucl Med Mol Imaging. 2023. PMID: 36416906
Autophagy in cancer development, immune evasion, and drug resistance.
Niu X, You Q, Hou K, Tian Y, Wei P, Zhu Y, Gao B, Ashrafizadeh M, Aref AR, Kalbasi A, Cañadas I, Sethi G, Tergaonkar V, Wang L, Lin Y, Kang D, Klionsky DJ. Niu X, et al. Among authors: you q. Drug Resist Updat. 2025 Jan;78:101170. doi: 10.1016/j.drup.2024.101170. Epub 2024 Nov 15. Drug Resist Updat. 2025. PMID: 39603146 Review.
Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer.
You Q, Shi HY, Gong CF, Tian XY, Li S. You Q, et al. Eur Rev Med Pharmacol Sci. 2020 Jan;24(16):8243. doi: 10.26355/eurrev_202001_22583. Eur Rev Med Pharmacol Sci. 2020. PMID: 32894524
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originality of data and figures, "Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer, by Q. You, H …
Since this article has been suspected of research misconduct and the corresponding authors did not respond to our request to prove originali …
1,628 results